Speaker Profile
Chief Business Officer, ChromaCode
Biography
Padma Sundar has close to 15 years of experience in the genomics and molecular diagnostics industry with leadership roles in strategy, marketing, sales, and reimbursement at Oncocyte, Roche Sequencing, Guardant Health and Affymetrix. She is experienced in securing high value reimbursement values and launching multiple ground-breaking technologies in the oncology field. Padma began her career as a consultant with McKinsey and company. She has a bachelors in chemistry and an MBA and Masters in Public Health from UC Berkeley.
Talk
Enabling dPCR to Displace NGS Assays
ChromaCode’s unique ability to interrogate more than one target per color channel on digital PCR instruments enables applications that might otherwise require NGS. Featured example applications include fast turnaround time (a) bespoke MRD assays and (b) donor-derived cell-free DNA testing of transplant patients.
Clinical Dx Showcase:
ChromaCode
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2024 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
